Literature DB >> 15496626

Therapeutic potential of RNA interference.

Mario Stevenson1.   

Abstract

Mesh：

Year:  2004        PMID： 15496626     DOI： 10.1056/NEJMra045004

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  41 in total

Review 1.  Tumor-targeted drug delivery with aptamers.

Authors:  Y Zhang; H Hong; W Cai
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Neuro-oncology in a nutshell.

Authors:  Joachim M Baehring
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

Review 3.  RNA interference in neuroscience: progress and challenges.

Authors:  Victor M Miller; Henry L Paulson; Pedro Gonzalez-Alegre
Journal:  Cell Mol Neurobiol       Date:  2005-12       Impact factor: 5.046

4.  Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs.

Authors:  Rosario Sabariegos; Mireia Giménez-Barcons; Natalia Tàpia; Bonaventura Clotet; Miguel Angel Martínez
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  E. coli RNase III(E38A) generates discrete-sized products from long dsRNA.

Authors:  Jianping Xiao; Caitlin E Feehery; George Tzertzinis; Claude V Maina
Journal:  RNA       Date:  2009-03-04       Impact factor: 4.942

6.  Reversal of multi-drug resistance by vector-based-shRNA-mdr1 in vitro and in vivo.

Authors:  Shi Lu; Qi Huang; Zehua Wang; Yinfeng Song; Lijun Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

Review 7.  Application of RNA interference in treating human diseases.

Authors:  S Abdolhamid Angaji; Sara Sadate Hedayati; Reihane Hosein Poor; Safoura Madani; Sanaz Samad Poor; Samin Panahi
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

8.  Inhibitory effect of antisense oligonucleotide targeting TIMP-2 on immune-induced liver fibrosis.

Authors:  Qing-He Nie; Chuan-Long Zhu; Ya-Fei Zhang; Jie Yang; Jiu-Cong Zhang; Ren-Tao Gao
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

9.  96 shRNAs designed for maximal coverage of HIV-1 variants.

Authors:  Glen John McIntyre; Jennifer Lynne Groneman; Yi-Hsin Yu; Angel Jaramillo; Sylvie Shen; Tanya Lynn Applegate
Journal:  Retrovirology       Date:  2009-06-04       Impact factor: 4.602

10.  Functional delivery of siRNA in mice using dendriworms.

Authors:  Amit Agrawal; Dal-Hee Min; Neetu Singh; Haihao Zhu; Alona Birjiniuk; Geoffrey von Maltzahn; Todd J Harris; Deyin Xing; Stephen D Woolfenden; Phillip A Sharp; Alain Charest; Sangeeta Bhatia
Journal:  ACS Nano       Date:  2009-09-22       Impact factor: 15.881
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.